Rotman, Yaron

Publishing since 2006 (Baby)

Has published 9 publications in 5 years

Number of publications published per year by Rotman, Yaron. (Source : PubMed)

Distribution of publications types for Rotman, Yaron. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, Leff RD, Meek C, Rivera M, Ko M, Koh C, Rotman Y, Ghany MG, Haynes-Williams V, Neumann AU, Liang TJ, Hoofnagle JH. Ribavirin improves early responses to peginterferon through enhanced interferon signaling.  Gastroenterology  2010  
•  Rotman Y, Borg BB, Soza A, Feld JJ, Modi AA, Loomba R, Lutchman G, Rivera E, Doo E, Ghany MG, Heller T, Neumann AU, Liang TJ, Hoofnagle JH. Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response.  Aliment. Pharmacol. Ther.  2010  
•  Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y, Ghany MG, Hoofnagle JH, Liang TJ, Heller T, Rehermann B. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.  Gastroenterology  2010;138;1  
•  Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.  J. Virol.  2009;83;15  
•  Rotman Y, Brown TA, Hoofnagle JH. Evaluation of the patient with hepatitis B.  Hepatology  2009;49;5 Suppl  
•  Rotman Y, Katz L, Cohen M, Cohen-Ezra O, Manhaim V, Braun M, Ben-Ari Z, Tur-Kaspa R. Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis C.  J. Viral Hepat.  2009;16;5  
•  von Rosenvinge EC, Koh C, Rotman Y, Lim RM. Electronic clinical challenges and images in GI. Gastrointestinal malignant melanoma.  Gastroenterology  2008;135;1  
•  Schmilovitz-Weiss H, Niv Y, Pappo O, Halpern M, Sulkes J, Braun M, Barak N, Rotman Y, Cohen M, Waked A, Tur-Kaspa R, Ben-Ari Z. The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis.  J. Clin. Gastroenterol.  2008;42;4  
•  Cohen M, Bachmatov L, Ben-Ari Z, Rotman Y, Tur-Kaspa R, Zemel R. Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection.  Dig. Dis. Sci.  2007;52;9  
•  Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, Tur-Kaspa R, Ben-Ari Z. Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection.  J. Viral Hepat.  2006;13;10  

[ See timeline ] [ See all publications ]